GARY TOPPIN: Open Payments
NPI 1528328572 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 106 payments from 25 companies in 2025. Trend: 2023 $1,147 · 2024 $1,289 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $412 |
| Novo Nordisk Inc | 9 | $161 |
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| GlaxoSmithKline, LLC. | 10 | $137 |
| Exact Sciences Corporation | 5 | $77 |
| PFIZER INC. | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
Products named: QULIPTA, AIRSUPRA, UBRELVY, SHINGRIX, Cologuard Collection Kit, XIFAXAN, VRAYLAR, REXULTI.
Industry payments across NC — which companies pay providers there.
